Keyphrases
Preclinical Data
100%
Clinical Benefit
100%
Statins
100%
Anticancer Therapy
100%
Epidemiological Data
100%
Relapsed or Refractory multiple Myeloma
33%
Clinical Trials
16%
In Cancer
16%
Chemotherapy
16%
Epidemiological Study
16%
Hepatocellular Carcinoma
16%
Colorectal Cancer
16%
Oncology
16%
Cancer Mortality
16%
Cancer Incidence
16%
Patient Benefit
16%
Statin Therapy
16%
Immunomodulatory Properties
16%
Dosing Schedule
16%
Early Breast Cancer
16%
Antitumor Properties
16%
Antineoplastic Agents
16%
Drug Class
16%
Anticancer
16%
Relapsed or Refractory
16%
Pediatric Brainstem Tumors
16%
Relapsed or Refractory Acute Myeloid Leukemia
16%
Cholesterol Reduction
16%
Statin Use
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Statin (Protein)
33%
Chemotherapy
16%
Clinical Trial
16%
Breast Cancer
16%
Liver Cell Carcinoma
16%
Cancer Incidence
16%
Early Cancer
16%
Colorectal Carcinoma
16%
Neoplasm
16%
Acute Myeloid Leukemia
16%
Multiple Myeloma
16%
Brain Stem Tumor
16%